1. Market Research
  2. > Healthcare
  3. > Diagnostics Market Trends
  4. > MediPoint: Biopsy Devices - South America Analysis and Market Forecasts

MediPoint: Biopsy Devices - South America Analysis and Market Forecasts

Summary

Cancer is the uncontrolled growth of abnormal cells in the body. It can affect numerous organs and tissues of the body. When a patient is suspected of having a particular type of cancer, a biopsy procedure is performed to extract a target tissue sample for histological analysis. This intervention typically provides a definitive cancer diagnosis for the patient. Given that these procedures play such an important role in the diagnostic pathway for various cancers, medical device manufacturers have worked to develop biopsy devices that maximize the volume and quality of the tissue samples, as well as decrease their negative impact on the patient’s body. As seen with other medical device markets, less invasive biopsy techniques have entered the market and have established a new gold standard in many global regions.

A similar pattern in biopsy procedure volumes for the cancer indications covered in this report can be observed in the major South American market of Brazil as in the major European markets previously discussed. Both prostate and breast biopsy procedures account for the largest portion of the overall market.

Scope

- An overview of biopsy devices, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines.
- Annualized SA biopsy devices market revenue and future forecasts from 2010 to 2012, forecast for 7 years to 2019.
- Investigation of current and future market competition for biopsy devices.
- Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events.
- Competitor assessment including device approval analysis and device sales forecasts.
- Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast.
- Analysis of unmet needs within the market and opportunities for future players.
- Technology trends evaluation to assess strength of pipeline.
- An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines.
- Company profiles including business description, financial overview and SWOT analysis.
- Coverage of key market players.
- Strategic assessment of the biopsy devices sector through market impact analysis, future market scenario and company analysis.
- Direct quotes from Key Opinion Leaders (KOL).

Reasons to buy

- Understand the trends shaping and driving SA biopsy devices Market.
- Realize device preferences of physicians who have performed the tests already.
- Access market sizing, forecasts and quantified growth opportunities in SA biopsy devices market through 2019.
- Quantify candidate patient populations to better design product pricing & launch plans.
- Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape.
- Perform benchmarking analysis of growth opportunities against currently marketed products.
- Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition.
- Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products.
- Create an effective counter-strategy to gain a competitive advantage against those currently in the market.
- Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth.
- What’s the next big thing in SA biopsy devices market landscape? Identify, understand and capitalize.

Table Of Contents

MediPoint: Biopsy Devices - South America Analysis and Market Forecasts
1 Table of Contents

2 Introduction 13
2.1 Overview 13
2.2 Catalyst 14
2.3 Related Reports 14
3 Industry Overview 15
3.1 Types of Biopsies 15
3.1.1 Surgical Biopsy 15
3.1.2 Fine Needle Aspiration 15
3.1.3 Core Needle Biopsy 16
3.1.4 Vacuum-Assisted Biopsy 17
3.2 Biopsy Procedure Trends 17
3.2.1 South America 17
3.3 Market Access to Cancer Screening Programs 18
3.3.1 Regulation 18
3.3.2 Biopsy Device Adoption Patterns 21
3.3.3 Reimbursement Trends 25
3.4 Regulatory Issues/Recalls 27
3.5 Mergers and Acquisitions/Key Partnerships 28
3.5.1 Hologic Acquires Suros Surgical Systems 28
3.5.2 C. R. Bard Acquires SenoRx 28
3.5.3 Devicor Medical Products Acquires Breast Care Portfolio from Ethicon Endo-Surgery 28
3.6 Economic Impact of Cancer Screening and Treatment 29
3.7 Additional Indications for Biopsy Devices 30
4 Unmet Needs 31
4.1 Overview 31
4.2 More Efficient Screening Tests for Prostate Cancer 31
4.3 More Efficient Screening Tests for Breast Cancer 32
4.4 More Efficient Screening Guidelines for Thyroid Cancer 32
4.5 Screening Tests That Can Provide Histological Analysis In Situ 33
5 Market Opportunity Analysis 34
5.1 Increase Marketing for Vacuum-Assisted Biopsy Devices in European Countries 34
5.2 Bundling Solutions 35
5.3 Focus Efforts on China's Increasing Adoption of VAB Devices 36
5.4 Market for Prostate Cancer Screening Coverage in Europe 36
6 Market Drivers and Barriers 38
6.1 Market Drivers 38
6.1.1 Inadequate Screening Tests for Particular Cancers 38
6.1.2 Demand for Minimally-Invasive Biopsy Techniques 39
6.1.3 Increased Adherence to Certain Cancer Screening Guidelines 39
6.1.4 Aging Patient Population 40
6.2 Market Barriers 41
6.2.1 Increased Competition from Other Cancer Diagnostic Tests 41
6.2.2 Breast Biopsy Reimbursement Bundling 44
6.2.3 Decreased Adherence to Certain Cancer Screening Guidelines 47
6.2.4 Benefits of Mass Prostate Cancer Screening Being Outweighed by Risks 47
7 Competitive Assessment 49
7.1 Overview 49
7.2 Classification Based on System 49
7.2.1 Vacuum-Assisted Biopsy Devices 49
7.2.2 Core Needle Biopsy Devices 51
7.2.3 Fine Needle Aspiration Devices 52
8 Pipeline Assessment 53
8.1 Overview 53
8.1.1 Optical Biopsy 53
8.1.2 Liquid Biopsy 54
9 Clinical Trial Analysis 56
10 Current and Future Players 58
10.1 Trends in Corporate Strategy 58
10.2 Company Profiles 58
10.2.1 Argon Medical Devices 58
10.2.2 Boston Scientific 61
10.2.3 Cardinal Health 64
10.2.4 CareFusion Corporation 65
10.2.5 Cook Medical 67
10.2.6 C. R. Bard 70
10.2.7 Devicor Medical Products 76
10.2.8 DTR Medical 80
10.2.9 Gallini Medical Devices 81
10.2.10 Hologic 84
10.2.11 INRAD 87
10.2.12 Intact Medical Corporation 89
10.2.13 TSK Laboratory 91
11 Market Outlook 93
11.1 Company Market Share 93
11.1.1 Vacuum-Assisted Biopsy Market Share 93
11.1.2 Core Needle Biopsy/Fine Needle Aspiration Market Share 94
11.2 By Geography 95
11.2.1 Brazil 95
12 Appendix 97
12.1 Bibliography 97
12.2 Abbreviations 105
12.3 Report Methodology 108
12.3.1 Overview 108
12.3.2 Coverage 108
12.3.3 Primary Research 108
12.3.4 Secondary Research 109
12.3.5 Forecasting Methodology 110
12.4 Key Opinion Leaders Included in This Study 110
12.5 About the Authors 111
12.5.1 Joseph A. Gregory, Analyst, Surgical Devices 111
12.5.2 Derek Archila, MBA, Director of Research and Analysis, Medical Devices 111
12.6 Global Head of Healthcare 112
12.6.1 Bonnie Bain, Ph.D., Global Head of Healthcare 112
12.7 About MediPoint 113
12.8 About GlobalData 113
12.9 Disclaimer 113

1.1 List of Tables

Table 1: Biopsy Device Adoption Patterns in Diagnosing Prostate Cancer, Global, 2013 and 2019 22
Table 2: Biopsy Device Adoption Patterns in Diagnosing Breast Cancer, Global, 2013 and 2019 23
Table 3: Biopsy Device Adoption Patterns in Diagnosing Lung Cancer, Global, 2013 and 2019 24
Table 4: Biopsy Device Adoption Patterns in Diagnosing Liver Cancer, Global, 2013 and 2019 24
Table 5: Biopsy Device Adoption Patterns in Diagnosing Thyroid Cancer, Global, 2013 and 2019 25
Table 6: Age Demographics, Age >65 Years, Global, 2013 40
Table 7: Stereotactic Breast Biopsy Ambulatory Surgery Center Billing, 2011 45
Table 8: Stereotactic Breast Biopsy Physician Billing, 2011 45
Table 9: Company Profile - Argon Medical Devices 59
Table 10: Product Portfolio - Argon Medical Devices 60
Table 11: Argon Medical Devices, SWOT Analysis, 2013 60
Table 12: Company Profile - Boston Scientific 61
Table 13: Product Portfolio - Boston Scientific 63
Table 14: Boston Scientific SWOT Analysis, 2013 63
Table 15: Company Profile - Cardinal Health 64
Table 16: Product Portfolio - Cardinal Health 65
Table 17: Cardinal Health SWOT Analysis, 2013 65
Table 18: Company Profile - CareFusion Corporation 66
Table 19: Product Portfolio - CareFusion 67
Table 20: CareFusion, SWOT Analysis, 2013 67
Table 21: Company Profile - Cook Medical 68
Table 22: Product Portfolio - Cook Medical 69
Table 23: Cook Medical, SWOT Analysis, 2013 70
Table 24: Company Profile - C. R. Bard 71
Table 25: Product Portfolio - C. R. Bard 71
Table 26: C.R. Bard, SWOT Analysis, 2013 75
Table 27: Company Profile - Devicor Medical Products 76
Table 28: Product Portfolio - Devicor Medical Products 79
Table 29: Devicor Medical Products SWOT Analysis, 2013 79
Table 30: Company Profile - DTR Medical 80
Table 31: Product Portfolio - DTR Medical 80
Table 32: DTR Medical SWOT Analysis, 2013 81
Table 33: Company Profile - Gallini Medical Devices 82
Table 34: Product Portfolio - Gallini Medical Devices 83
Table 35: Gallini Medical Devices SWOT Analysis, 2013 83
Table 36: Company Profile - Hologic 84
Table 37: Product Portfolio - Hologic 86
Table 38: Hologic SWOT Analysis, 2013 86
Table 39: Company Profile - INRAD 87
Table 40: Product Portfolio - INRAD 88
Table 41: INRAD SWOT Analysis, 2013 88
Table 42: Company Profile - Intact Medical Corporation 89
Table 43: Product Portfolio - Intact Medical Corporation 90
Table 44: Intact Medical Corporation SWOT Analysis, 2013 90
Table 45: Company Profile - TSK Laboratory 91
Table 46: Product Portfolio - TSK Laboratory 92
Table 47: TSK Laboratory SWOT Analysis, 2013 92
Table 48: VAB, Global Market Share, 2013 94
Table 49: CNB/FNA, Global Market Share, 2013 95
Table 50: Brazil Biopsy Devices Sales ($m) Forecast, 2010-2019 96

1.2 List of Figures

Figure 1: Biopsy Procedure Volumes: All Cancer Indications, Brazil, 2010-2019 18
Figure 2: EnCor Breast Biopsy System 72
Figure 3: EnCor Enspire Breast Biopsy System 73
Figure 4: EnCor Ultra Breast Biopsy System 73
Figure 5: Finesse Ultra Breast Biopsy System 74
Figure 6: Vacora Breast Biopsy System 75
Figure 7: Original Mammotome System 77
Figure 8: Mammotome Elite 78
Figure 9: Mammotome Revolve 79
Figure 10: VAB, Global Market Share, 2013 94
Figure 11: CNB/FNA, Global Market Share, 2013 95
Figure 12: Brazil Biopsy Devices Sales ($) Forecast, 2010-2019 96

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Ahmad

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers
Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

Liquid Biopsy Market: Global Industry Analysis and Opportunity Assessment 2016-2026

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

Report Synopsis This report by Future Market Insights (FMI) examines the ‘Liquid Biopsy Market’ for the period 2016–2026. The primary objective of the report is to offer updates and information ...

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

Breast Biopsy Device Market Analysis By Test Type, By Product, By Guidance Type, By Region And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The breast biopsy device market is expected to reach USD 911.2 million by 2024, according to a new report by Grand View Research, Inc. The Breast biopsy device market is projected to grow at a productive ...

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

Liquid Biopsy Market Size & Forecast By Application, By Sample Type, By Biomarker Type, By Technology and Trend Analysis from 2013 to 2030

  • $ 4950
  • Industry report
  • September 2016
  • by Grand View Research

Global liquid biopsies market is anticipated to reach 5,958.3 million by 2030, according to a new report by Grand View Research, Inc. As these less invasive biopsies are able to address a number of significant ...


Download Unlimited Documents from Trusted Public Sources

Biopsy Industry in the US

  • October 2016
    7 pages
  • Biopsy  

    Magnetic Resona...  

    Cancer  

  • United States  

View report >

Biopsy Industry in the US

  • August 2016
    2 pages
  • Biopsy  

  • United States  

    North America  

View report >

Biopsy Industry in the US

  • August 2016
    4 pages
  • Biopsy  

  • United States  

View report >

Related Market Segments :

Biopsy

ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.